Sfoglia per RIVISTA
BLOOD
Collezione AOU Città della Salute di Torino

  

Items : 43

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma. in Blood / Blood. 2024 Feb 15;143(7):592-596. doi: 10.1182/blood.2023022080.

2024
AOU Città della Salute di Torino

Paris L; Zambello R; Mancuso K; Gamberi B; Palmas AD; Gozzetti A; Cellini C; Ballanti S; Velluti C; Vincelli ID; Ronconi S; Pavone V; Grasso M; Ledda A; Oliva S; Corradini P; Morè S; Belotti A; Rota-Scalabrini D; Bertuglia G; D'Agostino M; Petrucci MT; Bruno B; Musto P; Gay F;

2024
AOU Città della Salute di Torino

Efficace F; Kicinski M; Coens C; Suciu S; van der Velden WJFM; Noppeney R; Chantepie S; Griskevicius L; Neubauer A; Audisio E; Luppi M; Fuhrmann S; Foà R; Crysandt M; Gaidano G; Vrhovac R; Venditti A; Posthuma EFM; Candoni A; Baron F; Legrand O; Mengarelli A; Fazi P; Vignetti M; Giraut A; Wijermans PW; Huls G; Lübbert M;

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. in Blood / Blood. 2024 Apr 4;143(14):1399-1413. doi: 10.1182/blood.2023021349.

2024
AOU Città della Salute di Torino

Crespiatico I; Zaghi M; Mastini C; D'Aliberti D; Mauri M; Mercado CM; Fontana D; Spinelli S; Crippa V; Inzoli E; Manghisi B; Civettini I; Ramazzotti D; Sangiorgio V; Gengotti M; Brambilla V; Aroldi A; Banfi F; Barone C; Orsenigo R; Riera L; Riminucci M; Corsi A; Breccia M; Morotti A; Cilloni D; Roccaro A; Sacco A; Stagno F; et alii...

Looking for a needle in the haystack of CLL. in Blood / Blood. 2023 Feb 2;141(5):445-447. doi: 10.1182/blood.2022018077.

2023
AOU Città della Salute di Torino

Ferrero S; Genuardi E;

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma. in Blood / Blood. 2022 Sep 22;140(12):1378-1389. doi: 10.1182/blood.2021014270.

2022
AOU Alessandria
AOU Città della Salute di Torino

Hohaus S; Re F; Petrini M; Pavone V; Castellino C; Zanni M; Casaroli I; Benedetti F; Stefani PM; De Luca G; Mantoan B; Evangelista A; Ferrante M; Ghislieri M; Alessandria B; Zaccaria GM; Drandi D; Genuardi E; Grimaldi D; Ferrero S; Musuraca G; Cascavilla N; Ghiggi C; Liberati AM; Cortelazzo S; Ladetto M;

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse. in Blood / Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560.

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Chiappella A; Sartori R; Vitagliano O; Mannina D; Morello L; Arcari A; Nicoli P; Williams ME; Angelillo P; Marin-Niebla A; Cencini E; van Meerten T; Mocikova H; Duglosz-Danecka M; Pagani C; Auer RL; Bernard S; Infante G; Iadecola S; Muzi C; Crucitti L; Giné E; Klener P; Tucker D; Eyre TA; Cheah CY; Rusconi C; Sciarra R; Stefani PM; et alii...

High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. in Blood / Blood. 2022 Mar 10;139(10):1557-1563. doi: 10.1182/blood.2021012890.

2022
AOU Città della Salute di Torino

Kolijn PM; Hosnijeh FS; Späth F; Hengeveld PJ; Agathangelidis A; Saleh M; Casabonne D; Benavente Y; Jerkeman M; Agudo A; Barricarte A; Besson C; Sánchez MJ; Chirlaque MD; Masala G; Sacerdote C; Grioni S; Schulze MB; Nieters A; Engelfriet P; Hultdin M; McKay JD; Vermeulen RCH; Langerak AW;

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. in Blood / Blood. 2022 Mar 10;139(10):1588-1592. doi: 10.1182/blood.2021014124.

2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Busca A; Rá?il Z; Hernández-Rivas JÁ; Jaksic O; Jiménez-Lorenzo MJ; Nunes-Rodrigues R; González-López TJ; Karlsson LK; Córdoba-Mascuñano R; Glenthøj A; Loureiro-Amigo J; Malak S; Ribera-Santa Susana JM; Serrano L; Weinbergerová B; Bilgin YM; Calbacho M; Labrador J; Sili U; van Doesum J; Dragonetti G; Falces-Romero I; Gomes-Silva M; Itri F; Lamure S; López-García A; Marchesi F; Salmanton-García J; et alii...

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.

2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Pagliuca A; Passamonti F; Bonanni M; Labrador J; Rahimli L; Verga L; Cattaneo C; Adži?-Vuki?evi? T; Machado M; Gräfe S; Sili U; Hanáková M; Nucci M; Mladenovi? M; Liévin R; Prezioso L; Rá?il Z; Guidetti A; Demirkan F; Sacchi MV; Fernández N; Zambrotta G; Fouquet G; Marchetti M; Batini? J; Aujayeb A; de Jonge N; de Ramón C; et alii...

2022
AOU Alessandria
AOU Città della Salute di Torino

Ranghetti P; Capasso A; Perotta E; Varettoni M; Laurenti L; Rivela P; Coscia M; Sancetta R; Reda G; Motta M; Ferrario A; Deodato M; Moia R; Farina L; Schiattone L; Albi E; Scarano E; Heltai S; Scarfò L; Colia M; Ghia P;

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. in Blood / Blood. 2022 Apr 21;139(16):2499-2511. doi: 10.1182/blood.2021014506.

2022
AOU Città della Salute di Torino

Wilson MR; Eyre TA; Kirkwood AA; Wong Doo N; Soussain C; Choquet S; Martinez-Calle N; Preston G; Ahearne M; Schorb E; Moles-Moreau MP; Ku M; Rusconi C; Khwaja J; Narkhede M; Lewis KL; Calimeri T; Durot E; Renaud L; Øvlisen AK; McIlroy G; Ebsworth TJ; Elliot J; Santarsieri A; Ricard L; Shah N; Liu Q; Zayac AS; Vassallo F; et alii...

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma. in Blood / Blood. 2021 Mar 4;137(9):1154-1165. doi: 10.1182/blood.2020008209.

2021
AOU Città della Salute di Torino

Anttila P; Capra M; Bringhen S; Dimopoulos M; Cavo M; Cole C; Gasparetto C; Hungria V; Jenner M; Vorobyev V; Ruiz EY; Yin JY; Saleem R; Hellet M; Macé S; Paiva B; Vij R;

2021
AOU Alessandria
AOU Città della Salute di Torino

Tacchetti P; Corradini P; Caravita di Toritto T; Patriarca F; Pompa A; Monaco F; Cellini C; Rota-Scalabrini D; Antonioli E; Bernardini A; Giuliani N; Galli M; Marasca R; Tosi P; Benevolo G; Capra A; Cascavilla N; Offidani M; Gaidano G; D'Agostino M; Bonello F; Larocca A; Boccadoro M; Bringhen S;

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. in Blood / Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201.

2021
AOU Alessandria
AOU Città della Salute di Torino

Gaidano G; Tedeschi A; Scarfò L; Cuneo A; Trentin L; Reda G; Orsucci L; De Paoli L; Montalbano MC; Perutelli F; Boccellato E; Gentile M; Pennese E; Rivela P; Marchetti M; Murru R; Laurenti L; Rigolin GM; Cassin R; Vassallo F; Visentin A; Zamprogna G; Schiattone L; Porrazzo M; Griggio V; Salvetti C; Vitale C; Mauro FR; Foà R; et alii...

2021
AOU Città della Salute di Torino

Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M;

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia. in Blood / Blood. 2021 Aug 19;138(7):571-583. doi: 10.1182/blood.2021010735.

2021
AOU Città della Salute di Torino

Palandri F; Rossi E; Bartoletti D; Ferretti A; Ruggeri M; Lucchini E; Carrai V; Barcellini W; Patriarca A; Rivolti E; Consoli U; Cantoni S; Oliva EN; Chiurazzi F; Caocci G; Giuffrida G; Borchiellini A; Auteri G; Baldacci E; Carli G; Nicolosi D; Sutto E; Carpenedo M; Cavo M; Mazzucconi MG; Zaja F; De Stefano V; Rodeghiero F; Vianelli N; et alii...

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide. in Blood / Blood. 2021 Apr 22;137(16):2267-2271. doi: 10.1182/blood.2020008609.

2021
AOU Città della Salute di Torino

Fürstenau M; Fink AM; Schilhabel A; Weiss J; Robrecht S; Eckert R; de la Serna J; Crespo M; Coscia M; Vitale C; Böttcher S; Weppner G; Ritgen M; Stilgenbauer S; Tausch E; Fischer K; Hallek M; Eichhorst B; Brüggemann M; Herling CD;

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. in Blood / Blood. 2020 May 21;135(21):1833-1846. doi: 10.1182/blood.2019003807.

2020
AOU Città della Salute di Torino

Royal V; Leung N; Troyanov S; Nasr SH; Écotière L; LeBlanc R; Adam BA; Angioi A; Alexander MP; Asunis AM; Barreca A; Bianco P; Cohen C; Drosou ME; Fatima H; Fenoglio R; Gougeon F; Goujon JM; Herrera GA; Knebelmann B; Lepori N; Maletta F; Manso R; Motwani SS; Pani A; Rabant M; Rennke HG; Rocatello D; Rosenblum F; et alii...

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Barbui T; Rambaldi A; Vannucchi AM; Alvarez-Larran A; Griesshammer M; Marchetti M; Isfort S; Recasens V; Tieghi A; McMullin MF; Cacciola R; Carli G; Benevolo G; Beggiato E; Angona A; Fox ML; Lunghi F; Perez-Encinas M; Wille K; Gomez M; Erez D; Rapezzi D; Elli EM; Palova M; Guglielmelli P; Stephenson C; Casetti IC; Rumi E; Patriarca A; et alii...

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. in Blood / Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.

2020
AOU Città della Salute di Torino

Brandão LR; Albisetti M; Halton J; Bomgaars L; Chalmers E; Mitchell LG; Nurmeev I; Svirin P; Kuhn T; Zapletal O; Tartakovsky I; Simetzberger M; Huang F; Sun Z; Kreuzer J; Gropper S; Brueckmann M; Luciani M;

2020
AOU Città della Salute di Torino

Chari A; Samur MK; Martinez-Lopez J; Cook G; Biran N; Yong K; Hungria V; Engelhardt M; Gay F; García Feria A; Oliva S; Oostvogels R; Gozzetti A; Rosenbaum C; Kumar S; Stadtmauer EA; Einsele H; Beksac M; Weisel K; Anderson KC; Mateos MV; Moreau P; San-Miguel J; Munshi NC; Avet-Loiseau H;

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.

2020
ASL Asti
AOU Città della Salute di Torino

Trentin L; Mauro FR; Gattei V; Ibatici A; Orsucci L; Rigolin GM; Pietrasanta D; Re F; De Paoli L; Marchetti M; Quaglia FM; Varettoni M; Reda G; Scarfò L; Cuneo A; Laurenti L; Marasca R; Foà R;

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study. in Blood / Blood. 2019 Sep 5;134(10):798-801. doi: 10.1182/blood.2019001088. Epub 2019 Jul 10.

2019
AOU Città della Salute di Torino

Luminari S; Merli M; Rattotti S; Tarantino V; Marcheselli L; Cavallo F; Varettoni M; Bianchi B; Merli F; Tedeschi A; Cabras G; Re F; Visco C; Torresan Delamain M; Cencini E; Spina M; Ferrero S; Ferrari A; Deodato M; Mannina D; Annibali O; Rago A; Orsucci L; Defrancesco I; Frigeni M; Cesaretti M; Arcaini L;

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study. in Blood / Blood. 2019 Nov 14;134(20):1708-1711. doi: 10.1182/blood.2019001617.

2019
AOU Alessandria
AOU Città della Salute di Torino

Borchiellini A; Motta G; Rambaldi A; Passamonti F; Lucchini E; Carli G; Santi RM; Volpetti S; Quaresimini G; Merli M; Valeri F; Romano A; Rodeghiero F; Visco C; d'Amore ESG; Ruggeri M;

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies. in Blood / Blood. 2019 Jan 10;133(2):156-167. doi: 10.1182/blood-2018-05-850826. Epub 2018 Nov 19.

2019
AOU Città della Salute di Torino

Deaglio S; Bertoni F; Rossi A; Riccio A; Audrito V; Cascione L; Todoerti K; Omedè P; Pullano V; Pellegrino E; Bandini C; Mereu E; Vitale N; Garaffo G; Riganti C; Bergaggio E; Neri A; Palumbo A; Piva R; Bergaggio E; Riganti C; Garaffo G; Vitale N; Mereu E; Bandini C; Pellegrino E; Pullano V; Omedè P; Todoerti K; et alii...

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. in Blood / Blood. 2019 Feb 28;133(9):919-926. doi: 10.1182/blood-2018-07-862862. Epub 2019 Jan 7.

2019
AOU Città della Salute di Torino

Klanova M; Sehn LH; Bence-Bruckler I; Cavallo F; Jin J; Martelli M; Stewart D; Vitolo U; Zaja F; Zhang Q; Mattiello F; Sellam G; Punnoose EA; Szafer-Glusman E; Bolen CR; Oestergaard MZ; Fingerle-Rowson GR; Nielsen T; Trneny M;

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. in Blood / Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4.

2018
AOU Città della Salute di Torino

van Rhee F; Voorhees P; Dispenzieri A; Fosså A; Srkalovic G; Ide M; Munshi N; Schey S; Streetly M; Pierson SK; Partridge HL; Mukherjee S; Shilling D; Stone K; Greenway A; Ruth J; Lechowicz MJ; Chandrakasan S; Jayanthan R; Jaffe ES; Leitch H; Pemmaraju N; Chadburn A; Lim MS; Elenitoba-Johnson KS; Krymskaya V; Goodman A; Hoffmann C; Zinzani PL; et alii...

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial. in Blood / Blood. 2017 Apr 20;129(16):2328-2330. doi: 10.1182/blood-2017-01-764258. Epub 2017 Mar 6.

2017
AOU Città della Salute di Torino

Zinzani PL; Pellegrini C; Chiappella A; Di Rocco A; Salvi F; Cabras MG; Argnani L; Stefoni V;

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. in Blood / Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Liberati AM; Guglielmelli T; Ledda A; Zambello R; Ruggeri M; Maisnar V; Ciccone G; Conticello C; Pulini S; Bernardini A; Musolino C; Giuliani N; Gentili S; Pietrantuono G; De Paoli L; Falcone AP; Mina R; Patriarca F; Benevolo G; Offidani M; Bringhen S; Magarotto V; Montefusco V; Hajek R; Boccadoro M; Palumbo A;

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. in Blood / Blood. 2016 Jun 9;127(23):2833-40. doi: 10.1182/blood-2016-01-694604. Epub 2016 Apr 18.

2016
AOU Città della Salute di Torino

Jakubowiak A; Offidani M; Pégourie B; De La Rubia J; Garderet L; Laribi K; Bosi A; Marasca R; Laubach J; Mohrbacher A; Carella AM; Singhal AK; Tsao LC; Lynch M; Bleickardt E; Jou YM; Robbins M; Palumbo A;

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. in Blood / Blood. 2016 Jan 14;127(2):221-32. doi: 10.1182/blood-2014-12-614503. Epub 2015 Oct 13.

2016
AOU Città della Salute di Torino

Rabadan R; Bertoni F; Falini B; Neri A; Deaglio S; Serra S; Tiacci E; Rinaldi A; Novero D; Mathew S; Abate F; Barreca A; Circosta P; Machiorlatti R; Caputo M; Vitale N; Garaffo G; Bergaggio E; Agnelli L; Kwee I; Mereu E; Scarfò I; Pellegrino E; Inghirami G; Piva R;

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AO Ordine Mauriziano
AOU Città della Salute di Torino

Zinzani PL; Massaia M; Moreno C; Del Poeta G; Perbellini O; Marasca R; Neri A; Tedeschi A; Rigolin GM; Motta M; Coscia M; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Cortelezzi A; Mauro FR; Morabito F; Visco C; Bulian P; Chiarenza A; Ghilardi G; Cerri M; De Paoli L; Terzi-di-Bergamo L; Rossi D; Montillo M; et alii...

How I treat fragile myeloma patients. in Blood / Blood. 2015 Nov 5;126(19):2179-85. doi: 10.1182/blood-2015-05-612960. Epub 2015 Aug 31.

2015
AOU Città della Salute di Torino

Larocca A; Palumbo A;

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. in Blood / Blood. 2015 Mar 26;125(13):2068-74. doi: 10.1182/blood-2014-12-615187. Epub 2015 Jan 27.

2015
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV;

Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma. in Blood / Blood. 2015 Jan 15;125(3):449-56. doi: 10.1182/blood-2014-05-576256. Epub 2014 Nov 14.

2015
AOU Città della Salute di Torino

Palumbo A; Lonergan S; de Weerdt O; Broyl A; van Marwijk-Kooy M; Vellenga E; Kersten MJ; van der Holt B; Asselbergs E; Zweegman S; Sonneveld P; Lokhorst H;

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. in Blood / Blood. 2015 Jan 1;125(1):111-23. doi: 10.1182/blood-2014-07-589069. Epub 2014 Nov 3.

2015
AOU Città della Salute di Torino

Wolberger C; Garcia JG; Gaidano G; Rizzi M; Wang T; Inghirami G; Rossi D; Maffei R; Vaisitti T; Coscia M; Arruga F; Mazzola F; Brusa D; Serra S; Audrito V; Raffaelli N; Deaglio S;

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. in Blood / Blood. 2015 Aug 20;126(8):950-6. doi: 10.1182/blood-2014-12-616474. Epub 2015 Jun 18.

2015
AOU Città della Salute di Torino

Ceriani L; Martelli M; Zinzani PL; Ferreri AJ; Botto B; Stelitano C; Gotti M; Cabras MG; Rigacci L; Gargantini L; Merli F; Pinotti G; Mannina D; Luminari S; Stathis A; Russo E; Cavalli F; Giovanella L; Johnson PW; Zucca E;

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. in Blood / Blood. 2014 Jul 3;124(1):63-9. doi: 10.1182/blood-2014-03-563759. Epub 2014 May 22.

2014
AOU Città della Salute di Torino

Bringhen S; Petrucci MT; Larocca A; Conticello C; Rossi D; Magarotto V; Musto P; Boccadifuoco L; Offidani M; Omedé P; Gentilini F; Ciccone G; Benevolo G; Genuardi M; Montefusco V; Oliva S; Caravita T; Tacchetti P; Boccadoro M; Sonneveld P; Palumbo A;

The impact of response on bone-directed therapy in patients with multiple myeloma. in Blood / Blood. 2013 Oct 24;122(17):2974-7. doi: 10.1182/blood-2013-04-498139. Epub 2013 Aug 23.

2013
AOU Città della Salute di Torino

Larocca A; Child JA; Cook G; Jackson GH; Russell N; Szubert A; Gregory WM; Brioli A; Owen RG; Drayson MT; Wu P; Palumbo A; Boccadoro M; Davies FE; Morgan GJ;

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

2013
AOU Città della Salute di Torino

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. in Blood / Blood. 2013 Aug 22;122(8):1376-83. doi: 10.1182/blood-2013-02-483073. Epub 2013 Jun 17.

2013
AOU Città della Salute di Torino

Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A;

2012
AOU Città della Salute di Torino

Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M;

Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination. in Blood / Blood. 2012 Oct 18;120(16):3222-8. doi: 10.1182/blood-2012-04-423095. Epub 2012 Aug 27.

2012
AOU Città della Salute di Torino

Benevolo G; Stacchini A; Spina M; Ferreri AJ; Arras M; Bellio L; Botto B; Bulian P; Cantonetti M; Depaoli L; Di Renzo N; Di Rocco A; Evangelista A; Franceschetti S; Godio L; Mannelli F; Pavone V; Pioltelli P; Vitolo U; Pogliani EM;